| mHealth for tuberculosis treatment adherence: a framework to guide ethical planning, implementation, and evaluation MJ DiStefano, H Schmidt Global Health: Science and Practice 4 (2), 211-221, 2016 | 88* | 2016 |
| Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries SY Kang, MJ DiStefano, MP Socal, GF Anderson Health Affairs 38 (5), 804-811, 2019 | 38 | 2019 |
| Comparative Approaches to Drug Pricing SY Kang, G Bai, MJ DiStefano, MP Socal, F Yehia, GF Anderson Annual Review of Public Health 41 (1), 2020 | 31 | 2020 |
| Beyond the numbers: a critique of quantitative multi-criteria decision analysis MJ DiStefano, CB Krubiner International Journal of Technology Assessment in Health Care, https://doi …, 2020 | 22 | 2020 |
| Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs MJ DiStefano, SY Kang, F Yehia, C Morales, GF Anderson Value in Health, 2021 | 15 | 2021 |
| Ethics of mobile phone surveys to monitor non-communicable disease risk factors in low-and middle-income countries: A global stakeholder survey J Ali, MJ DiStefano, I Coates McCall, DG Gibson, GM Al Kibria, GW Pariyo, ... Global Public Health 14 (8), 1167-1181, 2019 | 15 | 2019 |
| Public opinion regarding US Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey MJ DiStefano, GC Alexander, D Polsky, GF Anderson Journal of the American Geriatrics Society, 2022 | 14 | 2022 |
| Critical Care Beds With Continuous Lateral Rotation Therapy to Prevent Ventilator-Associated Pneumonia and Hospital-Acquired Pressure Injury: A Cost-effectiveness Analysis. SY Kang, MJ DiStefano, F Yehia, MV Koszalka, WV Padula Journal of Patient Safety, 2019 | 11 | 2019 |
| Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity? MJ DiStefano, JS Levin AMA Journal of Ethics 21 (8), E679-685, 2019 | 10 | 2019 |
| Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising MJ DiStefano, JM Markell, CC Doherty, GC Alexander, GF Anderson JAMA 329 (5), 386-392, 2023 | 9 | 2023 |
| We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment V Charlton, M DiStefano, P Mitchell, L Morrell, L Rand, G Badano, ... Health Economics, Policy and Law, https://doi.org/10.1017/S174413312300003, 2023 | 8 | 2023 |
| Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance MJ DiStefano, SY Kang, S Parasrampuria, GF Anderson JAMA Health Forum 4 (5), e231090-e231090, 2023 | 8 | 2023 |
| The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa CB Krubiner, A Tugendhaft, MJ DiStefano, NW Barsdorf, MW Merritt, ... Value in Health Regional Issues 34, 23-30, 2023 | 6 | 2023 |
| Integrating health technology assessment and the right to health: a qualitative content analysis of procedural values in South African judicial decisions MJ DiStefano, S Abdool Karim, CB Krubiner Health Policy and Planning, 2021 | 6 | 2021 |
| Reflective solidarity as to provincial globalism and shared health governance MJ DiStefano, J Prah Ruger Diametros, 2015 | 6 | 2015 |
| Developing and Piloting a Context-Specified Ethics Framework for Health Technology Assessment: The South African Values and Ethics for Universal Health Coverage (SAVE-UHC) Approach CB Krubiner, NW Barsdorf, SJ Goldstein, A Mosam, S Potgieter, ... International Journal of Technology Assessment in Health Care 38 (1), e26, 2022 | 5 | 2022 |
| Introducing an Ethics Framework for health priority-setting in South Africa on the path to universal health coverage D Blaauw, C Chambers, T Chirwa, N Duba, L Gwyther, K Hofman, ... South African Medical Journal 112 (3), 240-244, 2022 | 4 | 2022 |
| Health Systems Stewardship, Governance, and Accountability: Issues of Public Health Ethics MJ DiStefano, JP Ruger The Oxford Handbook of Public Health Ethics, 115-126, 2019 | 4* | 2019 |
| Characterizing" Civil Unrest" as a Public Health Determinant MJ DiStefano American Journal of Public Health 108 (7), e20, 2018 | 4 | 2018 |
| Estimated savings from using added therapeutic benefit and therapeutic reference pricing in United States Medicare drug price negotiations MJ DiStefano, JF Levy, IC Odouard, GF Anderson Value in Health, DOI: 10.1016/j.jval.2023.08.004, 2023 | 3 | 2023 |
Gerard AndersonJohns HopkinsVerified email at jhu.edu
